Patent Assignment
Reel/Frame 020487/0321
Assignment of Assignor's Interest
Recorded: 2008-02-11
Pages: 21
Assignor
NEUROTECH, S.A.
Executed: 2007-10-25
Assignee
NEUROTECH USA, INC.
6 BLACKSTONE VALLEY PLACE, BUILDING 3, SUITE 307, LINCOLN, RHODE ISLAND, 02865
Covered Properties
(49)
Glucose Responsive Insulin Secreting Beta-Cell Lines and Method for Producing Same
Patent:
5,534,404 →
Application:
08/208,873 →
Method for Implanting Encapsulated Cells in a Host
Patent:
5,550,050 →
Application:
08/228,403 →
Microdrive for Use in Stereotactic Surgery
Patent:
5,643,286 →
Application:
08/265,242 →
Methods and Compositions of Growth Control for Cells Encapsulated Within Bioartificial Organs
Patent:
5,935,849 →
Application:
08/279,773 →
Nerve Guidance Channel Containing Bioartificial Three-Dimensional Hydrogel Extracellular Matrix Derivatized with Cell Adhesive Peptide Fragment
Patent:
5,834,029 →
Application:
08/280,646 →
Inner-Supported, Biocompatible Cell Capsules
Patent:
5,786,216 →
Application:
08/337,555 →
Controlling Proliferation of Cells Before and After Encapsulation in a Bioartificial Organ by Gene Transformation
Patent:
5,843,431 →
Application:
08/432,698 →
Methods and Compositions of Growth Control for Cells Encapsulated Within Bioartificial Organs
Patent:
5,840,576 →
Application:
08/445,193 →
Methods and Compositions of Growth Control for Cells Encapsulated Within Bioartificial Organs
Patent:
5,853,717 →
Application:
08/447,356 →
Methods and Compositions of Growth Control for Cells Encapsulated Within Bioartificial Organs
Patent:
5,833,979 →
Application:
08/447,771 →
A Method for Controlling the Distribution of Cells Within a Bioartificial Organ Using Polyethylene Oxide-Poly(Dimethylsiloxane)Copolymer
Patent:
5,776,747 →
Application:
08/447,778 →
Control of Cell Growth in a Bioartificial Organ with Extracellular Matrix Coated Microcarriers
Patent:
5,858,747 →
Application:
08/447,810 →
Mx-1 Conditionally Immortalized Cells
Patent:
6,392,118 →
Application:
08/447,997 →
Method for Controlling Prolifertion and Differentiation of Cells Encapsulated Within Bioartificial Organs
Patent:
5,795,790 →
Application:
08/448,201 →
Inner Supported Biocompatible Cell Capsules
Patent:
5,773,286 →
Application:
08/449,568 →
Delivery of Biologically Active Molecules Using Cells Contained in Bicompatible Immunoisolatory Capsules
Patent:
5,639,275 →
Application:
08/449,756 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Cells Contained in Biocompatible Capsules
Patent:
5,656,481 →
Application:
08/449,946 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent:
5,676,943 →
Application:
08/450,316 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent:
5,908,623 →
Application:
08/450,862 →
Compositions and Methods for the Delivery of Biologically Active Molecules Using Cells Contained in Biocompatible Capsules
Patent:
5,653,975 →
Application:
08/451,044 →
Glucose Responsive Insulin Secreting B-Cell Lines and Method for Producing Same
Patent:
5,712,159 →
Application:
08/461,302 →
Apparatus and Method for Storage and Transportation of Bioartificial Organs
Patent:
5,681,740 →
Application:
08/463,658 →
Glucose Responsive Insulin Secreting B-Cell Lines and Method for Producing Same
Patent:
5,773,255 →
Application:
08/464,974 →
Bioartificial Organ Containing Cells Encapsulated in a Permselective Polyether Suflfone Membrane
Patent:
5,837,234 →
Application:
08/488,317 →
Membrane Formed by an Acrylonitrile-Based Polymer
Patent:
5,720,969 →
Application:
08/535,213 →
Method for Treating Ophthalmic Diseases
Patent:
5,904,144 →
Application:
08/620,982 →
Device and Method for Encapsulated Gene Therapy
Patent:
6,027,721 →
Application:
08/650,726 →
Biocompatible Devices with Foam Scaffolds
Patent:
6,054,142 →
Application:
08/690,969 →
Microdrive for Use in Stereotactic Surgery
Patent:
5,871,487 →
Application:
08/814,594 →
Immortalized Retinal Pigmentary Epithelial Cell Lines and Their Applications
Patent:
6,183,735 →
Application:
08/973,553 →
Membrane Formed by an Acrylonitrile-Based Polymer
Patent:
6,180,007 →
Application:
09/016,518 →
Device and Method for Treating Ophthalmic Diseases
Patent:
6,299,895 →
Application:
09/155,066 →
Bioartificial Extracellular Matrix Containing Hydrogel Matrix Derivatized with Cell Adhesive Peptide Afragment
Patent:
6,156,572 →
Application:
09/160,654 →
Cell Surface Molecule-Induced Macrophage Activation
Patent:
6,197,294 →
Application:
09/178,869 →
Immortalized Retinal Cell Lines and Their Applications
Patent:
6,090,624 →
Application:
09/182,516 →
Biocompatible Devices with Foam Scaffolds
Patent:
6,231,879 →
Application:
09/230,506 →
Compositions for the Delivery of Biologically Active Molecules Using Genetically Altered Cells Contained in Biocompatible Immunoisolatory Capsules
Patent:
6,264,941 →
Application:
09/236,246 →
Cells or Tissue Attached to a Non- Degradable Filamentous Matrix Encapsulated by a Semi- Permeable Membrane
Patent:
6,303,136 →
Application:
09/289,999 →
ARPE-19 as a plateform cell line for encapsulated cell-based delivery
Patent:
6,361,771 →
Application:
09/543,119 →
Retinal Cell Lines with Extended Life-Span and Their Applications
1gG /transferrin receptor fusion protein
Patent:
6,225,448 →
Application:
09/562,544 →
Device Containing Cell-Supporting Yarn Matrix Encapsulated in a Semi-Permeable Membrane
Patent:
6,627,422 →
Application:
09/673,339 →
Cell Surface Molecule-Induced Macrophage Activation
Mx-1 Conditionally Immortalized Cells
Arpe-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery
Patent:
7,115,257 →
Application:
09/958,040 →
Device and Method for Treating Ophthalmic Diseases
Device and Method for Treating Ophthalmic Diseases
Cell Surface Molecule-Induced Macrophage Activation
ARPE-19 as platform cell line for encapsulated cell-based delivery
Application:
11/543,015 →
Publication:
US 2007/0071734
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 13, 1994
From: LAURANCE, MEGAN E.; KNAACK, DAVID; FIORE, DEBORAH M.; HEGRE, ORION D.
To: CYTOTHERAPEUTICS
Reel/Frame 007020/0956 →
Assignment of Assignor's Interest
Jul 5, 1994
From: HOLLAND, LAURA M.; HAMMANG, JOSEPH P.; RUDNICK, SETH A.; LYSAGHT, MICHAEL J.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007050/0432 →
Assignment of Assignor's Interest
Aug 8, 1994
From: WARNER, NICHOLAS; GODDARD, MOSES; MILLS, JOHN
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007090/0364 →
Assignment of Assignor's Interest
Nov 7, 1994
From: BELLAMKONDA, RAVI; RANIERI, JOHN P.; AEBISCHER, PATRICK
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007196/0406 →
Assignment of Assignor's Interest
Nov 14, 1994
From: SCHINSTINE, MALCOLM; SHOICHET, MOLLY S.; GENTILE, FRANK T.; HAMMANG, JOSEPH P.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007198/0318 →
Assignment of Assignor's Interest
Apr 3, 1995
From: DIONNE, KEITH E.; HEGRE, ORION D.; FLANAGAN, THOMAS R.; HAZLETT, TYRONE F.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007404/0697 →
Assignment of Assignor's Interest
Jul 13, 1995
From: SCHINSTINE, MALCOLM; SHOICHET, MOLLY S.; GENTILE, FRANK T.; HAMMANG, JOSEPH P.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007604/0344 →
Assignment of Assignor's Interest
Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0912 →
Assignment of Assignor's Interest
Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007581/0661 →
Assignment of Assignor's Interest
Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANS, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0697 →
Assignment of Assignor's Interest
Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007556/0745 →
Assignment of Assignor's Interest
Jul 28, 1995
From: BAETGE, EDWARD E.; HAMMANG, JOSEPH P.; GENTILE, FRANK T.; LINDNER, MARK D.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007559/0299 →
Assignment of Assignor's Interest
Aug 10, 1995
From: MESSIER, KENNETH A.; WARNER, NICHOLAS F.
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007579/0751 →
Assignment of Assignor's Interest
Aug 15, 1995
From: GENTILE, FRANK T.; WINN, SHELLEY R.; LYSAGHT, MICHAEL; BAURMEISTER, ULRICH
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007597/0468 →
Assignment of Assignor's Interest
Jan 18, 1996
From: GENTILE, FRANK; SHOICHET, MOLLY; HARRIS, MILTON
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007896/0650 →
Assignment of Assignor's Interest
May 8, 1996
From: MESSING, ALBEE
To: CYTOTHERAPEUTICS, INC.
Reel/Frame 007931/0762 →
Assignment of Assignor's Interest
Jul 18, 1996
From: CYTOTHERAPEUTICS, INC.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSITY
Reel/Frame 008050/0160 →
Assignment of Assignor's Interest
Feb 7, 2000
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 010567/0917 →
This Is a Corrected Assignment to Remove the 41 United Stated Patents Listed on the Attached Schedule a from the Assignment Recorded on March 8, 2000 at Reel/Frame 010567/0917. the Conveying Party Did Not Have an Assignable Interest in These Patents. Thus, These Documents Were Inadvertently Included on the Recordation Form Cover Sheet Filed on February 7, 2000 and Should Be Removed.
Oct 12, 2005
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 017145/0800 →
Corrective Assignment to Remove Property Numbers: 4,868,121, 5,322,790 and 07/922,111, Previously Recorded at Reel 010567 Frame 0917.
Oct 12, 2005
From: CYTO THERAPEUTIS, INC.
To: NEUROTECH S.A.
Reel/Frame 016902/0648 →
Assignment of Assignor's Interest
Dec 12, 2005
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 017073/0187 →
Assignment of Assignor's Interest
Apr 5, 2006
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 017794/0001 →
Assignment of Assignor's Interest
Aug 22, 2006
From: CYTOTHERAPEUTICS, INC.
To: NEUROTECH S.A.
Reel/Frame 018207/0810 →
Security Agreement
Dec 23, 2010
From: NEUROTECH USA, INC.
To: LFG AMERICA PTY LIMITED
Reel/Frame 025562/0340 →